Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 195

1.

Hepatitis C treatment uptake and response among human immunodeficiency virus/hepatitis C virus-coinfected patients in a large integrated healthcare system.

Lam JO, Hurley LB, Chamberland S, Champsi JH, Gittleman LC, Korn DG, Lai JB, Quesenberry CP Jr, Ready J, Saxena V, Seo SI, Witt DJ, Silverberg MJ, Marcus JL.

Int J STD AIDS. 2019 Jun;30(7):689-695. doi: 10.1177/0956462419836520. Epub 2019 May 2.

2.

Prevalence of Spontaneous Clearance of Hepatitis C Virus Infection Doubled From 1998 to 2017.

Seo S, Silverberg MJ, Hurley LB, Ready J, Saxena V, Witt D, Hare CB, Champsi JH, Korn DG, Pauly MP, Chamberland S, Lai JB, Marcus JL.

Clin Gastroenterol Hepatol. 2019 Apr 19. pii: S1542-3565(19)30425-2. doi: 10.1016/j.cgh.2019.04.035. [Epub ahead of print]

PMID:
31009792
3.

Multi-Descriptor Read Across (MuDRA): A Simple and Transparent Approach for Developing Accurate Quantitative Structure-Activity Relationship Models.

Alves VM, Golbraikh A, Capuzzi SJ, Liu K, Lam WI, Korn DR, Pozefsky D, Andrade CH, Muratov EN, Tropsha A.

J Chem Inf Model. 2018 Jun 25;58(6):1214-1223. doi: 10.1021/acs.jcim.8b00124. Epub 2018 Jun 13.

PMID:
29809005
4.

Disparities in Initiation of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection in an Insured Population.

Marcus JL, Hurley LB, Chamberland S, Champsi JH, Gittleman LC, Korn DG, Lai JB, Lam JO, Pauly MP, Quesenberry CP Jr, Ready J, Saxena V, Seo SI, Witt DJ, Silverberg MJ.

Public Health Rep. 2018 Jul/Aug;133(4):452-460. doi: 10.1177/0033354918772059. Epub 2018 May 11.

5.

No Difference in Effectiveness of 8 vs 12 Weeks of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C in Black Patients.

Marcus JL, Hurley LB, Chamberland S, Champsi JH, Gittleman LC, Korn DG, Lai JB, Lam JO, Pauly MP, Quesenberry CP Jr, Ready J, Saxena V, Seo SI, Witt DJ, Silverberg MJ.

Clin Gastroenterol Hepatol. 2018 Jun;16(6):927-935. doi: 10.1016/j.cgh.2018.03.003. Epub 2018 Mar 11.

6.

Forensic bitemark identification: weak foundations, exaggerated claims.

Saks MJ, Albright T, Bohan TL, Bierer BE, Bowers CM, Bush MA, Bush PJ, Casadevall A, Cole SA, Denton MB, Diamond SS, Dioso-Villa R, Epstein J, Faigman D, Faigman L, Fienberg SE, Garrett BL, Giannelli PC, Greely HT, Imwinkelried E, Jamieson A, Kafadar K, Kassirer JP, Koehler J', Korn D, Mnookin J, Morrison AB, Murphy E, Peerwani N, Peterson JL, Risinger DM, Sensabaugh GF, Spiegelman C, Stern H, Thompson WC, Wayman JL, Zabell S, Zumwalt RE.

J Law Biosci. 2016 Nov 23;3(3):538-575. doi: 10.1093/jlb/lsw045. eCollection 2016 Dec.

7.

Critical international normalized ratio results after hours: To call or not to call?

Korn D, Sean McMurtry M, George-Phillips K, Bungard TJ.

Can Fam Physician. 2017 Mar;63(3):e170-e176.

8.

Eutrophication, microbial-sulfate reduction and mass extinctions.

Schobben M, Stebbins A, Ghaderi A, Strauss H, Korn D, Korte C.

Commun Integr Biol. 2015 Dec 4;9(1):e1115162. doi: 10.1080/19420889.2015.1115162. eCollection 2016 Jan-Feb. Review.

9.

The Evolution and Development of Cephalopod Chambers and Their Shape.

Lemanis R, Korn D, Zachow S, Rybacki E, Hoffmann R.

PLoS One. 2016 Mar 10;11(3):e0151404. doi: 10.1371/journal.pone.0151404. eCollection 2016.

10.

Lasing in silicon-organic hybrid waveguides.

Korn D, Lauermann M, Koeber S, Appel P, Alloatti L, Palmer R, Dumon P, Freude W, Leuthold J, Koos C.

Nat Commun. 2016 Mar 7;7:10864. doi: 10.1038/ncomms10864.

11.
12.

Flourishing ocean drives the end-Permian marine mass extinction.

Schobben M, Stebbins A, Ghaderi A, Strauss H, Korn D, Korte C.

Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):10298-303. doi: 10.1073/pnas.1503755112. Epub 2015 Aug 3.

13.

[Adherence to psychopharmacological treatment: Psychotherapeutic strategies to enhance adherence].

Lencer R, Korn D.

Nervenarzt. 2015 May;86(5):637-46; quiz 647-8. doi: 10.1007/s00115-015-4275-z. German.

PMID:
25903501
14.

Indirect costs: Cash is no gravy train.

Korn D.

Nature. 2015 Jan 22;517(7535):438. doi: 10.1038/517438b. No abstract available.

PMID:
25612045
15.

Low-power silicon-organic hybrid (SOH) modulators for advanced modulation formats.

Lauermann M, Palmer R, Koeber S, Schindler PC, Korn D, Wahlbrink T, Bolten J, Waldow M, Elder DL, Dalton LR, Leuthold J, Freude W, Koos C.

Opt Express. 2014 Dec 1;22(24):29927-36. doi: 10.1364/OE.22.029927.

PMID:
25606923
16.

Thymic and bone marrow output in individuals with 22q11.2 deletion syndrome.

Dar N, Gothelf D, Korn D, Frisch A, Weizman A, Michaelovsky E, Carmel M, Yeshayahu Y, Dubnov-Raz G, Pessach IM, Simon AJ, Lev A, Somech R.

Pediatr Res. 2015 Apr;77(4):579-85. doi: 10.1038/pr.2015.14. Epub 2015 Jan 12.

PMID:
25580739
17.

Vitamin D intoxication: case report.

Marins TA, Galvão Tde F, Korkes F, Malerbi DA, Ganc AJ, Korn D, Wagner J, Guerra JC, Borges Filho WM, Ferracini FT, Korkes H.

Einstein (Sao Paulo). 2014 Apr;12(2):242-4. English, Portuguese.

18.

Silicon-organic hybrid (SOH) frequency comb sources for terabit/s data transmission.

Weimann C, Schindler PC, Palmer R, Wolf S, Bekele D, Korn D, Pfeifle J, Koeber S, Schmogrow R, Alloatti L, Elder D, Yu H, Bogaerts W, Dalton LR, Freude W, Leuthold J, Koos C.

Opt Express. 2014 Feb 10;22(3):3629-37. doi: 10.1364/OE.22.003629.

PMID:
24663654
19.

Conflicts of interest in medical education: recommendations from the Pew task force on medical conflicts of interest.

Korn D, Carlat D.

JAMA. 2013 Dec 11;310(22):2397-8. doi: 10.1001/jama.2013.280889. No abstract available.

PMID:
24327035
20.

Novel SMARCAL1 bi-allelic mutations associated with a chromosomal breakage phenotype in a severe SIOD patient.

Simon AJ, Lev A, Jeison M, Borochowitz ZU, Korn D, Lerenthal Y, Somech R.

J Clin Immunol. 2014 Jan;34(1):76-83. doi: 10.1007/s10875-013-9957-3. Epub 2013 Nov 7.

PMID:
24197801
21.

Extinction space--a method for the quantification and classification of changes in morphospace across extinction boundaries.

Korn D, Hopkins MJ, Walton SA.

Evolution. 2013 Oct;67(10):2795-810. doi: 10.1111/evo.12162. Epub 2013 Jun 7.

PMID:
24094334
22.

Newborn screening for severe T and B cell immunodeficiency in Israel: a pilot study.

Somech R, Lev A, Simon AJ, Korn D, Garty BZ, Amariglio N, Rechavi G, Almashanu S, Zlotogora J, Etzioni A.

Isr Med Assoc J. 2013 Aug;15(8):404-9.

23.

Silicon-organic hybrid (SOH) IQ modulator using the linear electro-optic effect for transmitting 16QAM at 112 Gbit/s.

Korn D, Palmer R, Yu H, Schindler PC, Alloatti L, Baier M, Schmogrow R, Bogaerts W, Selvaraja SK, Lepage G, Pantouvaki M, Wouters JM, Verheyen P, Van Campenhout J, Chen B, Baets R, Absil P, Dinu R, Koos C, Freude W, Leuthold J.

Opt Express. 2013 Jun 3;21(11):13219-27. doi: 10.1364/OE.21.013219.

PMID:
23736576
24.

Using carrier-depletion silicon modulators for optical power monitoring.

Yu H, Korn D, Pantouvaki M, Van Campenhout J, Komorowska K, Verheyen P, Lepage G, Absil P, Hillerkuss D, Alloatti L, Leuthold J, Baets R, Bogaerts W.

Opt Lett. 2012 Nov 15;37(22):4681-3.

PMID:
23164878
25.

Quantification of ontogenetic allometry in ammonoids.

Korn D.

Evol Dev. 2012 Nov-Dec;14(6):501-14. doi: 10.1111/ede.12003.

PMID:
23134208
26.

Second-order nonlinear silicon-organic hybrid waveguides.

Alloatti L, Korn D, Weimann C, Koos C, Freude W, Leuthold J.

Opt Express. 2012 Aug 27;20(18):20506-15. doi: 10.1364/OE.20.020506.

PMID:
23037098
27.

Performance tradeoff between lateral and interdigitated doping patterns for high speed carrier-depletion based silicon modulators.

Yu H, Pantouvaki M, Van Campenhout J, Korn D, Komorowska K, Dumon P, Li Y, Verheyen P, Absil P, Alloatti L, Hillerkuss D, Leuthold J, Baets R, Bogaerts W.

Opt Express. 2012 Jun 4;20(12):12926-38. doi: 10.1364/OE.20.012926.

PMID:
22714320
28.

Early evolutionary trends in ammonoid embryonic development.

De Baets K, Klug C, Korn D, Landman NH.

Evolution. 2012 Jun;66(6):1788-806. doi: 10.1111/j.1558-5646.2011.01567.x. Epub 2012 Feb 14.

PMID:
22671547
29.

Interview: A perspective on personalized medicine: Dr David Korn.

Korn D.

Per Med. 2012 May;9(3):259-263. doi: 10.2217/pme.11.71.

30.

Instantiating a vision: creating the new pathology department at Stanford Medical School.

Korn D.

Annu Rev Pathol. 2012;7:1-33. doi: 10.1146/annurev-pathol-011811-132447. Epub 2011 Aug 12.

PMID:
21838547
31.

42.7 Gbit/s electro-optic modulator in silicon technology.

Alloatti L, Korn D, Palmer R, Hillerkuss D, Li J, Barklund A, Dinu R, Wieland J, Fournier M, Fedeli J, Yu H, Bogaerts W, Dumon P, Baets R, Koos C, Freude W, Leuthold J.

Opt Express. 2011 Jun 6;19(12):11841-51. doi: 10.1364/OE.19.011841.

PMID:
21716417
32.

Reduced propagation loss in silicon strip and slot waveguides coated by atomic layer deposition.

Alasaarela T, Korn D, Alloatti L, Säynätjoki A, Tervonen A, Palmer R, Leuthold J, Freude W, Honkanen S.

Opt Express. 2011 Jun 6;19(12):11529-38. doi: 10.1364/OE.19.011529.

PMID:
21716384
33.

Pathological gambling and posttraumatic stress disorder: a study of the co-morbidity versus each alone.

Najavits LM, Meyer T, Johnson KM, Korn D.

J Gambl Stud. 2011 Dec;27(4):663-83. doi: 10.1007/s10899-010-9230-0.

PMID:
21191636
34.

Lottery promotions at the point-of-sale in Ontario, Canada.

Planinac LC, Cohen JE, Reynolds J, Robinson DJ, Lavack A, Korn D.

J Gambl Stud. 2011 Jun;27(2):345-54. doi: 10.1007/s10899-010-9208-y.

PMID:
20577789
35.

A new history and discussion of 180-day exclusivity.

Korn DE, Lietzan E, Scott SW.

Food Drug Law J. 2009;64(2):335-90.

PMID:
19999288
36.

Efficacy of add-on montelukast in patients with non-controlled asthma: a Belgian open-label study.

Korn D, Van den Brande P, Potvin E, Dramaix M, Herbots E, Peché R.

Curr Med Res Opin. 2009 Feb;25(2):489-97. doi: 10.1185/03007990802667937 .

PMID:
19192994
37.

Contributions of international medical graduates to US biomedical research: The experience of US medical schools.

Alexander H, Heinig SJ, Fang D, Dickler H, Korn D.

J Investig Med. 2007 Dec;55(8):410-4. doi: 10.2310/6650.2007.00025.

PMID:
18163966
38.

Congress responds to the IOM drug safety report--in full.

Psaty BM, Korn D.

JAMA. 2007 Nov 14;298(18):2185-7. No abstract available.

PMID:
18000202
39.

Missing the mark on biomedical research.

Korn D, Heinig SJ.

Nature. 2007 Nov 1;450(7166):27. No abstract available.

PMID:
17972858
40.

Sustaining the engine of U.S. biomedical discovery.

Heinig SJ, Krakower JY, Dickler HB, Korn D.

N Engl J Med. 2007 Sep 6;357(10):1042-7. No abstract available.

PMID:
17804852
41.
42.

Issues in the interpretation of 180-day exclusivity.

Lietzan E, Korn DE.

Food Drug Law J. 2007;62(1):49-75. No abstract available.

PMID:
17444026
43.
44.

Engaging youth about gambling using the internet: The YouthBet.net website.

Korn D, Murray M, Morrison M, Reynolds J, Skinner HA.

Can J Public Health. 2006 Nov-Dec;97(6):448-53.

PMID:
17203723
45.

The Food and Drug Administration's evolving regulation of press releases: limits and challenges.

Vodra WW, Cortez NG, Korn DE.

Food Drug Law J. 2006;61(4):623-51. No abstract available.

PMID:
17180767
46.

Is there a crisis of accountability in the American research university?

Smith BL, Korn D.

Minerva. 2000;38(2):129-45. No abstract available.

PMID:
17152687
47.

Promoting translational and clinical science: the critical role of medical schools and teaching hospitals.

Dickler HB, Korn D, Gabbe SG.

PLoS Med. 2006 Sep;3(9):e378. No abstract available.

48.

Principles for strengthening the integrity of clinical research.

Korn D, Ehringhaus S.

PLoS Clin Trials. 2006 May;1(1):e1. No abstract available.

49.

Cytokines in the nasal washes of children with respiratory syncytial virus bronchiolitis.

Midulla F, Tromba V, Lo Russo L, Mileto F, Sabatino G, Sgarrella M, Panuska JR, Manganozzi L, Korn D, Moretti C.

Int J Immunopathol Pharmacol. 2006 Jan-Mar;19(1):231-5.

PMID:
16569362
50.

The costs of institutional review boards.

Dickler HB, Korn D.

N Engl J Med. 2005 Jul 21;353(3):315-7; author reply 315-7. No abstract available.

PMID:
16034023

Supplemental Content

Support Center